Aneurysmal Subarachnoid Hemorrhage
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Rocheerythropoietin beta
Fresenius KabiDiben 1.5 kcal HP
Clinical Trials (2)
Total enrollment: 108 patients across 2 trials
Erythropoietin Therapy for Subarachnoid Hemorrhage
Start: Apr 2005Est. completion: Mar 200780 patients
Phase 2Completed
Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin Therapy
Start: Aug 2015Est. completion: Sep 201828 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space